🇺🇸 ALSEROXYLON in United States

ALSEROXYLON (ALSEROXYLON) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: NDA008867
  • Marketing authorisation holder: 3M
  • Local brand name: RAUWILOID
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

ALSEROXYLON in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is ALSEROXYLON approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for ALSEROXYLON in United States?

Marketing authorisation holder not available in our data.